Gene · 9290
Papers1,426
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,426
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cannabidiol Inhibits the Proliferation and Invasiveness of Prostate Cancer Cells. | J Nat Prod | 2023 | 37703852 | PubTator, text mining | PubMed |
| Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. | Drugs | 2023 | 37695433 | PubTator, text mining | PubMed |
| A comprehensive survival and prognosis analysis of GPR55 expression in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37688769 | PubTator, text mining | PubMed |
What Is the Role of Palmitoylethanolamide Co-Ultramicronized with Luteolin on the Symptomatology Reported by Patients Suffering from Long COVID? A Retrospective Analysis Performed by a Group of General Practitioners in a Real-Life Setting. | Nutrients | 2023 | 37686733 | PubTator, text mining | PubMed |
| Lipid Metabolism Reprogramming of Immune Cells in Acne: An Update. | Clin Cosmet Investig Dermatol | 2023 | 37675181 | PubTator, text mining | PubMed |
| High-CBD cannabis extracts inhibit the expression of proinflammatory factors via miRNA-mediated silencing in human small intestinal epithelial cells. | Heliyon | 2023 | 37664748 | PubTator, text mining | PubMed |
| Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies. | Ther Adv Neurol Disord | 2023 | 37655228 | PubTator, text mining | PubMed |
| miR-153-3p suppresses the differentiation and proliferation of neural stem cells via targeting GPR55. | Aging (Albany NY) | 2023 | 37642951 | PubTator, text mining | PubMed |
| Therapeutic Potential of Cannabinoids in Glaucoma. | Pharmaceuticals (Basel) | 2023 | 37631064 | PubTator, text mining | PubMed |
| Treating Epilepsy with Natural Products: Nonsense or Possibility? | Pharmaceuticals (Basel) | 2023 | 37630977 | PubTator, text mining | PubMed |
| Functional Changes of White Matter Are Related to Human Pain Sensitivity during Sustained Nociception. | Bioengineering (Basel) | 2023 | 37627873 | PubTator, text mining | PubMed |
| Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies. | Biomedicines | 2023 | 37626685 | PubTator, text mining | PubMed |
| Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism. | Sci Rep | 2023 | 37612324 | PubTator, text mining | PubMed |
| The combined signatures of G protein-coupled receptor family and immune landscape provide a prognostic and therapeutic biomarker in endometrial carcinoma. | J Cancer Res Clin Oncol | 2023 | 37584707 | PubTator, text mining | PubMed |
| Changes in plasma endocannabinoids concentrations correlate with 18F-FDG PET/MR uptake in brown adipocytes in humans. | Front Mol Biosci | 2023 | 37564131 | PubTator, text mining | PubMed |
| Lysophosphatidylglucoside/GPR55 signaling promotes foam cell formation in human M2c macrophages. | Sci Rep | 2023 | 37544935 | Swiss-Prot, curated | PubMed |
| Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence. | Front Psychiatry | 2023 | 37533892 | PubTator, text mining | PubMed |
| Could cannabinoids provide a new hope for ovarian cancer patients? | Pharmacol Res Perspect | 2023 | 37526235 | PubTator, text mining | PubMed |
| Should oncologists trust cannabinoids? | Front Pharmacol | 2023 | 37521486 | PubTator, text mining | PubMed |
| The Skin and Natural Cannabinoids-Topical and Transdermal Applications. | Pharmaceuticals (Basel) | 2023 | 37513960 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9290/papers?page=8